The identification of a single-nucleotide polymorphism downstream of the IL22RA2 gene as an MS risk loci as well as the implication of IL-22 in various immune-mediated diseases led us to study this cytokine according to MS disease activity. The gene discussed is IL22RA2; the disease is myeloid sarcoma.